15 June 2026
Herbert Smith Freehills Kramer advises on the financing for GSK plc’s US$10.6 billion acquisition of Nuvalent Inc.
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Will Nevin Lead | Herbert Smith Freehills Kramer | Partner | UK Finance | Not stated |
| Shael Geffen | Herbert Smith Freehills Kramer | Associate | UK Finance | Australia |
| Mukuma Kawesha | Herbert Smith Freehills Kramer | Associate | UK Finance | Not stated |
| Zhiwan Rong | Herbert Smith Freehills Kramer | Trainee | UK Finance | Not stated |
| Gabrielle Wong | Herbert Smith Freehills Kramer | Partner | US Finance | Not stated |
| Chelsea Fish | Herbert Smith Freehills Kramer | Senior associate | US Finance | Not stated |
| Meenakshi Kurpad | Herbert Smith Freehills Kramer | Associate | US Finance | Not stated |
| Aurell Taussig | Herbert Smith Freehills Kramer | Partner | UK Tax | Not stated |
| Perminder Gainda | Herbert Smith Freehills Kramer | Senior associate | UK Tax | Not stated |
| Pamela Capps | Herbert Smith Freehills Kramer | Partner | US Tax | Not stated |
| Mariya Khvatskaya | Herbert Smith Freehills Kramer | Senior associate | US Tax | Not stated |
8 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 10.6bn (US$10.6 billion)
- What the figure measures
- Total transaction value
- Client
- arranging banksLenders
- Counterparties
- GSK plc (Buy-side)
Nuvalent, Inc. (Target)